Results 271 to 280 of about 53,113 (297)

Combined Immunotherapy in Treating Patients with Advanced Hepatocellular Carcinoma. [PDF]

Biomedicines
Li KHL, Leung R, Li BCW, Cheung TT, Yau T.   +4 more
europepmc   +1 more source

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial. [PDF]

Nat Commun
Provencio M, Campos B, Guirado M, Vila L, García Campelo R, Dorta M, Vázquez Estévez S, Ferrández A, Sala MÁ, Ortega AL, Blasco A, Insa A, Areses MC, Sullivan I, Lopez R, Calvo V, Rodriguez-Abreu D, Bosch-Barrera J, López-Martín A, Marsé R, Torrado L, Matskov K, Giner J, Fernández Bruno M, Sánchez Saugar E, Martínez-Toledo C, Mediavilla P, Romero A, Cruz-Bermúdez A.   +28 more
europepmc   +1 more source

Atezolizumab Plus Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma: An Institutional Experience. [PDF]

Biomedicines
Esmail A, Hamadneh Y, Khasawneh B, Al-Rawi M, Al-Najjar E, Dhillon V, Alhaj A, Rayyan Y, Abdelrahim M.   +8 more
europepmc   +1 more source

Rethinking evidence standards for men with metastatic prostate cancer in the post-androgen receptor pathway inhibitor setting: new insights from CONTACT-02. [PDF]

Transl Androl Urol
Takemura K, Yusasa T.
europepmc   +1 more source

The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma

Mizuki Ariga, Teiji Kuzuya, Hisanori Muto, Yoshihiko Tachi, Mariko Kobayashi, Haruo Sugiyama, Sayaka Morisaki, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka, Mitsuo Nagasaka, Ryoji Miyahara, Yoshiki Hirooka   +15 more
openalex   +1 more source

Correction: Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma. [PDF]

Front Pharmacol
Zhu Y, He C, Cao SC, Li HJ, Cai RX, Bai ZJ, Xia TX.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

Nature Medicine, 2022
, Marina Ruiz de Galarreta, Chih-Hung Hsu   +2 more
exaly  

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
, Florian Castet, Mala K Maini
exaly  

Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

Nature Medicine, 2022
Thomas Powles, Silke Gillessen, Edward E Kadel Iii   +2 more
exaly